Healthtech Startups
16,988 companies tagged Healthtech, with their investors and founders.
Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
2 investors
Tuli operates a network of UK pharmacies that function as diagnostic hubs, offering blood testing and clinical services directly to patients and healthcare providers through a simplified booking and sample collection process.
2 investors
TuMeke uses AI and computer vision to analyze how workers move and identify ergonomic risks without wearables or sensors, helping safety teams prevent musculoskeletal workplace injuries. The platform serves organizations aiming to proactively reduce injury risk among their frontline workforce.
2 investors
Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data. Founded out of EPFL's Laboratory for Data Security in 2021, it focuses initially on the health and medical research sector.
2 investors
Two Plus Fertility is a fertility and reproductive health service or platform. The specific page content does not provide details about the company's business model or services.
2 investors
TXP Medical develops and provides medical data systems for emergency, intensive care, and emergency-services settings (the NEXT Stage ER series) as well as an oncology research data system, along with a medical data platform, real-world data analysis, and clinical research support. The company, based in Tokyo, Japan, aims to integrate fragmented hospital medical data into connected clinical datasets for use in care, research, and healthcare policy.
2 investors
Tybrhealth develops the B3 GELโข System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.
2 investors
Type6 Therapeutics is a drug-discovery company developing kinase inhibitors that target the inactive OFF-state of kinases to improve selectivity and durability against cancers that evade existing therapies. Its lead program is a CDK2 inhibitor (CDK2i), with plans to expand into additional kinase targets across the human kinome.
2 investors
U-Ploid develops therapeutic treatments to address age-related infertility by preventing chromosome errors in eggs during IVF procedures. The company targets individuals and healthcare providers seeking effective reproductive health solutions for later-life family planning.
2 investors
Ubenwa develops AI technology that analyzes newborn cries to assess infant needs and provide caregivers with insights, available through lightweight integrations into consumer devices and a mobile app called Nanni AI.
2 investors
Fabric builds healthcare technology that unifies virtual and in-person care across intake, triage, routing, and treatment while automating clinical and administrative workflows for staff. It serves providers, payers, and employers through a nationwide provider network, with UCM Digital Health now part of Fabric following its acquisition.
2 investors
UHG, part of the MedHealth group, provides employment, medical opinion, advisory, rehabilitation, and return-to-work services to support people in achieving work and health outcomes. It operates across more than 300 locations in Australia, drawing on independent medical specialists spanning major medical and allied health disciplines.
2 investors
Ujala Cygnus Healthcare Services operates a chain of 25 NABH-accredited multi-super-speciality hospitals serving tier 2 and tier 3 towns of Northern India, with a focus on affordable secondary and tertiary care. Formed in 2019 from the merger of Ujala Healthcare and Cygnus Medicare, it runs Centres of Excellence in areas such as intensive care, cardiology, neurology, oncology, and trauma across states including Uttar Pradesh, Haryana, Uttarakhand, Jammu & Kashmir, and Punjab.
2 investors
Ultherapy develops FDA-cleared ultrasound devices that use microfocused ultrasound and real-time imaging to lift skin and stimulate collagen production without surgery. The company offers non-invasive aesthetic treatments for consumers seeking skin lifting and wrinkle reduction.
2 investors
Ultragenyx is a biotechnology company focused on developing treatments for patients living with rare genetic diseases. The company emphasizes a culture of generosity, curiosity, and inclusion among its team members.
2 investors
uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle. The company enables access to clinical research data and patient insights for pharmaceutical companies, researchers, and healthcare institutions developing new treatments.
2 investors
uMotif builds an eCOA/ePRO and patient-engagement platform for clinical research, enabling patients to track and report symptoms, outcomes, and other health data for trials. It serves the clinical research and life sciences industry with a patient-centered approach to data collection.
2 investors
Umps provides personal alarm and monitoring solutions for older adults seeking to maintain independent living at home rather than enter aged care facilities. The company develops evidence-based health interventions and care delivery tools specifically designed for seniors in Australia and beyond.
2 investors
Unbound offers a membership-based athletic performance testing service, providing assessments across blood biomarkers, VOโ max, cardiovascular fitness, musculoskeletal evaluation, hormones and mental performance, followed by a health report and personalised action plan. It targets serious and elite amateur athletes, bringing performance testing methods used with professional athletes to a wider audience, with a UK focus.
2 investors
Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.
2 investors
Unfabled offers menstrual and hormonal wellness products and personalized care for individuals across different life stages, including solutions for fertility, post-partum, menopause, PCOS, and endometriosis. The company serves people seeking trustworthy health information and validated product recommendations for women's health.
2 investors
United Family Healthcare (ๅ็ฆๅฎถๅป็) is a private healthcare provider operating hospitals and clinics that offer patient-centered medical services across the full life cycle, including preventive care, diagnosis, treatment, and rehabilitation. It serves patients in China with an evidence-based clinical approach.
2 investors
UnityAI provides an agentic AI platform that engages patients through voice, text, and email to automate scheduling, reminders, and guidance. It aims to reduce no-shows and improve patient access and treatment adherence for healthcare providers, supporting 90+ languages and 24/7 availability.
2 investors
Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation. It runs a discovery organization in Boulder, Colorado, aiming to create treatments for patients with unmet medical needs.
2 investors